Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
CRISPR Therapeutics
Sort By
Newest First
1 / 1
Gene Editing
Vertex Announces New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies
Vertex
PR-M06-20-NI-017
Jun 12, 2020
CRISPR-Cas9
How Close Is CRISPR to Eradicating Disease and Correcting Genetic Defects?
KshitiJ (TJ) Ladage
Nice Insight
PAP-Q1-20-NI-003
Mar 19, 2020
Cell and Gene Therapy
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001® for Severe Hemoglobinopathies
Vertex
PR-M11-19-NI-023
Nov 20, 2019
1 / 1
